Kidney Transplant Market Report 2025

The kidney transplant market size has grown steadily in recent years. It will grow from $6.15 billion in 2024 to $6.44 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to research and clinical trials, patient education and support, enhanced diagnostic tools, advancements in post-transplant care, immunosuppressive therapies.

The kidney transplant market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing demand for transplantation, development of immunomodulatory therapies, expansion of living donor pool, minimization of wait times, telemedicine for pre-transplant evaluation. Major trends in the forecast period include patient-centric care models, research in xenotransplantation, enhanced rejection monitoring, telemedicine for post-transplant care, expanded access to transplantation.

The anticipated increase in the occurrence of renal disorders and kidney failure is poised to drive the growth of the kidney transplant market in the future. Renal disorders and kidney failure refer to conditions where the kidneys cease to function, leading to an imbalance in bodily chemicals and the inability to eliminate waste and excess water from the blood. Kidney transplants become a necessity to restore kidney function and address the underlying causes of renal failure. According to the American Kidney Fund in 2023, 37 million Americans suffer from kidney disease, with approximately 130,000 Americans newly diagnosed with kidney failure in 2020. Consequently, the growing incidence of renal disorders and kidney failure serves as a significant driver for the expansion of the kidney transplant market.

The anticipated shortage of donor organs is expected to fuel the growth of the kidney transplant market. This shortage arises when the supply of available organs for transplantation falls short of the demand. The scarcity of donor organs intensifies the demand for kidney transplants, representing a critical and often life-saving intervention for individuals with kidney disorders. Life Source reported in March 2023 that every day, 17 individuals die while waiting for an organ transplant, and a new name is added to the transplant waiting list every 9 minutes. Currently, over 100,000 patients in the US are awaiting a second chance at a life-saving organ transplant. Thus, the shortage of donor organs acts as a driving force behind the expansion of the kidney transplant market.

Advancements in kidney transplantation techniques emerge as a noteworthy trend gaining traction in the kidney transplant market. Companies within the industry are dedicating efforts to developing innovative solutions for kidney transplants to maintain their competitive positions. Stanford Medicine, a US-based healthcare system, introduced the DISOT (dual immune/solid organ transplant) technique in June 2022 for pediatric kidney transplantation. This groundbreaking method involves transferring the donor's immune system to the recipient before the kidney transplant, eliminating the need for lifelong immune-suppressing drugs. The innovation brings significant benefits to patients by sparing them from the serious long-term side effects associated with immune-suppressing medications, including increased risks of cancer, diabetes, infections, and hypertension.

Major companies in the kidney transplant sector are adopting strategic partnerships to enhance the overall patient experience and provide more comprehensive solutions. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. For example, in April 2023, CareDx Inc., a US-based biotechnology research company, partnered with Miromatrix Medical Inc., a US-based life sciences company. This collaboration aims to expedite the development of bioengineered organs for human transplantation, combining expertise, resources, and market reach to contribute significantly to addressing the organ shortage crisis and improving the lives of transplant patients globally.

In January 2022, DaVita Inc., a US-based kidney dialysis services company, acquired MedSleuth Inc. for an undisclosed amount. Through this acquisition, DaVita Inc. seeks to alleviate access burdens on kidney and liver transplant candidates by connecting them to transplant centers, physicians, and care teams to enhance kidney and liver transplant outcomes. MedSleuth Inc., a US-based transplant software company, provides kidney transplantation technology services.

Major companies operating in the kidney transplant market include Pfizer Inc., Novartis AG, B. Braun Melsungen AG, Fresenius Medical Care AG & Co., Medtronic Plc., TransMedics Inc., Preservation Solution Inc., Organ Recovery Systems Inc., Transonic Systems Inc., DaVita Inc., Glycorex Transplantation AB, Astellas Pharma Inc., Veloxis Pharmaceuticals A/s, Immucor Inc., Penn Medicine, Sanofi S.A, Amgen Inc., Amyndas Pharmaceuticals, Abbvie Inc., Teva Pharmaceuticals Ltd., BiolifeSolutions, Bristol-Myers Squibb Company, CareDx Inc., CSL Behring, Grifols S.A., Kedrion Biopharma Inc.

North America was the largest region in the kidney transplant market in 2024. Europe is expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the kidney transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A kidney transplant is a surgical intervention involving the replacement of a diseased or non-functioning kidney with a healthy kidney from a donor. This procedure is considered as a treatment option for individuals facing end-stage kidney disease or severe kidney dysfunction that cannot be effectively managed through alternative therapies such as dialysis.

The primary types of kidney transplants include deceased-donor kidney transplants, living-donor kidney transplants, and expanded-criteria donor kidney transplants. In a deceased-donor kidney transplant, a kidney is obtained from a deceased donor and transplanted into a recipient experiencing end-stage renal disease (ESRD). This surgical procedure is conducted in both adult and pediatric patients and finds applications in areas such as drug delivery, capsule endoscopy, and patient monitoring. These procedures are carried out by various end users, including transplant centers, hospitals, and academic and research institutes.

The kidney transplant research report is one of a series of new reports that provides kidney transplant market statistics, including the kidney transplant industry's global market size, regional shares, competitors with a kidney transplant market share, detailed kidney transplant market segments, market trends and opportunities, and any further data you may need to thrive in the kidney transplant industry. This kidney transplant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The kidney transplant market includes revenues earned by entities by providing post-transplant care and monitoring services, dialysis services, rehabilitation services, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.